Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Citation
Taylor-Rowan , M , Kraia , O , Kolliopoulou , C , Cross , A J , Stewart , C , Myint , P K , McCleery , J & Quinn , T J 2022 , ' Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia. ' , Cochrane Database of Systematic Reviews , vol. 2021 , no. 11 , CD015196 . https://doi.org/10.1002/14651858.CD015196